Clinical Trial


Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)


Brief description

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Keywords

  •   Anaemia

Sponsored By

GlaxoSmithKline

Unique Study ID

NCT02876835

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

Novartis
36420, Andalusia, Alabama, United States
Distance from Current Trial is 0 miles

No Investigator Listed

Boehringer Ingelheim
36420, Andalusia, Alabama, United States
Distance from Current Trial is 0 miles

No Investigator Listed

Myovant Sciences GmbH
36420, Andalusia, Alabama, United States
Distance from Current Trial is 0 miles
View All